avVaa World Health Care Products, Inc. Signs Agreement with 3PL Worldwide, Inc., for Order Management & Fulfillment for avVaa’s Product
July 6, 2009 by BiotechSector.com
Filed under Biotech News
avVaa World Health Care Products Inc. (Pink Sheets: AVVH), a global biotechnology company, manufacturer and distributor of nationally branded therapeutic, natural skin and health care products, is pleased to announce that it has signed an agreement with 3PL Worldwide, Inc., for all Order Management & Fulfillment (www.3plworldwide.com).
Jack Farley CEO explains that “3PL Worldwide offers true multichannel support for all types of offer configurations – direct-to-consumer- e-commerce, catalog, mail order and consumer promotion markets. Each program is assigned a Client Services manager with overall responsibility for project performance.”
Randy Pulling VP Business Developments says, “at 3PL we believe the ideal way to minimize returns and suppress refunds is to do our job right at the outset. Orders are processed quickly, product is shipped accurately and packaging is designed for maximum endorsement and minimum weight.”
Randy Pulling, says that “3PL Worldwide lives up to our commitment to our clients and to their customers, and to protecting the bottom line each day by providing fast, flexible fulfillment. We combine the ideal in order management, logistics and fulfillment services, bi-coastal warehouse facilities, real-time reporting, and call center management to create happy customers one order at a time.”
3PL meets the demands of today’s fast-paced market. avVaa’s customers anticipate prompt service and swift delivery and marketers demand flexible, scalable logistic systems and up-to-the-minute reporting. The Company is chesty to have 3PL Worldwide as their vendor/partner for avVaa’s order management and fulfillment centre.
About avVaa World Health Care Products
avVaa World Health Care Products is a global biotechnology company that specializes in effective, all natural, therapeutic skin care products that improve calibre of life and well being for consumers. avVaa’s patented European skin care formulas are scientifically registered, FDA-Compliant, and were developed to relieve and treat the symptoms of common skin ailments, including eczema, psoriasis and acne. avVaa is poised to manufacture and market its OTC Neuroskin(r) line of skin care products through mass, food and drug channels in the United Says and globally. The Company’s secondary line of equine and pet care related products are already being distributed throughout all of Canada. For more information, visit: www.avvaa.com.
Safe Harbor: Statements contained in this press release that are not based upon current or historical fact are forward looking in nature. Such forward-looking statements are subject to risks and uncertainties, which could cause actual results to differ materially from estimated results. Management cautions that all statements as to future results of operations are necessarily subject to risks, uncertainties, and events that might be beyond the control of avVaa World Health Care Products, Inc. and no assurance can be given that such results will be achieved.
Potential risks and uncertainties include but are not limited to the capability to procure, properly price, retain, and successfully complete projects, the availability of technical personnel, changes in technology, and competition.






